End-of-day quote
Shenzhen S.E.
06:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
6.79
CNY
|
+5.60%
|
|
+7.78%
|
+28.36%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,019
|
5,028
|
5,443
|
7,513
|
4,128
|
3,963
|
Enterprise Value (EV)
1 |
4,813
|
5,793
|
6,493
|
8,360
|
4,697
|
4,249
|
P/E ratio
|
31.2
x
|
30.1
x
|
65.3
x
|
38.6
x
|
138
x
|
176
x
|
Yield
|
2.26%
|
6.03%
|
1.67%
|
-
|
-
|
0.66%
|
Capitalization / Revenue
|
5.67
x
|
6.24
x
|
7.75
x
|
8.71
x
|
6.32
x
|
6.38
x
|
EV / Revenue
|
6.79
x
|
7.18
x
|
9.25
x
|
9.69
x
|
7.19
x
|
6.84
x
|
EV / EBITDA
|
10.9
x
|
11.9
x
|
14.5
x
|
15.1
x
|
12.8
x
|
12.8
x
|
EV / FCF
|
20.2
x
|
163
x
|
190
x
|
-35.8
x
|
16.7
x
|
16.9
x
|
FCF Yield
|
4.95%
|
0.61%
|
0.53%
|
-2.79%
|
6%
|
5.9%
|
Price to Book
|
1.98
x
|
2.38
x
|
2.96
x
|
3.87
x
|
2.09
x
|
1.99
x
|
Nbr of stocks (in thousands)
|
758,322
|
758,322
|
758,117
|
749,094
|
749,094
|
749,094
|
Reference price
2 |
5.300
|
6.630
|
7.180
|
10.03
|
5.510
|
5.290
|
Announcement Date
|
3/29/19
|
3/30/20
|
4/22/21
|
4/27/22
|
4/26/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
708.7
|
806.3
|
702.3
|
862.6
|
653.2
|
621
|
EBITDA
1 |
441.6
|
487.2
|
446.6
|
552.6
|
366.6
|
330.7
|
EBIT
1 |
179
|
211.8
|
139.2
|
244.2
|
77.93
|
37.9
|
Operating Margin
|
25.26%
|
26.27%
|
19.82%
|
28.31%
|
11.93%
|
6.1%
|
Earnings before Tax (EBT)
1 |
143.8
|
188.8
|
94.21
|
218.9
|
35.3
|
14.81
|
Net income
1 |
127.9
|
166.5
|
86.63
|
192.7
|
33.12
|
19.1
|
Net margin
|
18.05%
|
20.65%
|
12.34%
|
22.34%
|
5.07%
|
3.08%
|
EPS
2 |
0.1700
|
0.2200
|
0.1100
|
0.2600
|
0.0400
|
0.0300
|
Free Cash Flow
1 |
238.4
|
35.49
|
34.16
|
-233.6
|
281.8
|
250.7
|
FCF margin
|
33.63%
|
4.4%
|
4.86%
|
-27.08%
|
43.14%
|
40.37%
|
FCF Conversion (EBITDA)
|
53.97%
|
7.29%
|
7.65%
|
-
|
76.87%
|
75.83%
|
FCF Conversion (Net income)
|
186.31%
|
21.31%
|
39.43%
|
-
|
850.64%
|
1,312.62%
|
Dividend per Share
2 |
0.1200
|
0.4000
|
0.1200
|
-
|
-
|
0.0350
|
Announcement Date
|
3/29/19
|
3/30/20
|
4/22/21
|
4/27/22
|
4/26/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
793
|
765
|
1,050
|
846
|
569
|
286
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.797
x
|
1.571
x
|
2.351
x
|
1.532
x
|
1.553
x
|
0.8655
x
|
Free Cash Flow
1 |
238
|
35.5
|
34.2
|
-234
|
282
|
251
|
ROE (net income / shareholders' equity)
|
6.35%
|
8.02%
|
4.41%
|
10.2%
|
1.72%
|
0.99%
|
ROA (Net income/ Total Assets)
|
2.99%
|
3.61%
|
2.24%
|
3.88%
|
1.36%
|
0.76%
|
Assets
1 |
4,279
|
4,619
|
3,860
|
4,971
|
2,434
|
2,523
|
Book Value Per Share
2 |
2.680
|
2.780
|
2.430
|
2.590
|
2.640
|
2.660
|
Cash Flow per Share
2 |
0.7400
|
0.6200
|
1.130
|
0.7500
|
0.5900
|
0.4600
|
Capex
1 |
205
|
306
|
288
|
233
|
52.4
|
75.9
|
Capex / Sales
|
28.86%
|
37.91%
|
41%
|
27%
|
8.03%
|
12.22%
|
Announcement Date
|
3/29/19
|
3/30/20
|
4/22/21
|
4/27/22
|
4/26/23
|
4/22/24
|
|
1st Jan change
|
Capi.
|
---|
| +28.36% | 702M | | 0.00% | 7.77B | | -20.42% | 2.61B | | -15.64% | 2.58B | | -29.66% | 1.78B | | -14.06% | 1.02B | | -12.87% | 998M | | +3.34% | 856M | | -2.70% | 736M | | -24.05% | 708M |
Testing Laboratories
|